A detailed history of Jpmorgan Chase & CO transactions in Biolife Solutions Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 285,735 shares of BLFS stock, worth $7.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
285,735
Previous 334,948 14.69%
Holding current value
$7.3 Million
Previous $6.21 Million 1.45%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$15.14 - $22.99 $745,084 - $1.13 Million
-49,213 Reduced 14.69%
285,735 $6.12 Million
Q1 2024

May 10, 2024

SELL
$15.35 - $18.82 $304,728 - $373,614
-19,852 Reduced 5.6%
334,948 $6.21 Million
Q4 2023

Feb 12, 2024

SELL
$8.99 - $16.86 $175,673 - $329,461
-19,541 Reduced 5.22%
354,800 $5.77 Million
Q3 2023

Nov 14, 2023

SELL
$10.81 - $22.96 $312,365 - $663,452
-28,896 Reduced 7.17%
374,341 $5.17 Million
Q2 2023

Aug 11, 2023

SELL
$17.19 - $24.34 $34,912 - $49,434
-2,031 Reduced 0.5%
403,237 $8.91 Million
Q1 2023

May 18, 2023

BUY
$17.67 - $26.07 $752,335 - $1.11 Million
42,577 Added 11.74%
405,268 $8.81 Million
Q1 2023

May 11, 2023

SELL
$17.67 - $26.07 $730,248 - $1.08 Million
-41,327 Reduced 10.23%
362,691 $7.89 Million
Q4 2022

Feb 13, 2023

SELL
$16.95 - $25.07 $28,001 - $41,415
-1,652 Reduced 0.41%
404,018 $7.35 Million
Q3 2022

Nov 14, 2022

SELL
$14.64 - $26.7 $719,980 - $1.31 Million
-49,179 Reduced 10.81%
405,670 $9.23 Million
Q2 2022

Aug 11, 2022

BUY
$10.54 - $24.2 $162,284 - $372,607
15,397 Added 3.5%
454,849 $6.28 Million
Q1 2022

May 11, 2022

SELL
$20.81 - $37.29 $668,479 - $1.2 Million
-32,123 Reduced 6.81%
439,452 $9.99 Million
Q4 2021

Feb 10, 2022

BUY
$32.99 - $58.55 $2.69 Million - $4.77 Million
81,435 Added 20.87%
471,575 $17.6 Million
Q3 2021

Nov 12, 2021

BUY
$42.03 - $60.5 $16.4 Million - $23.6 Million
390,140 New
390,140 $16.5 Million

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.09B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.